MQS Management LLC Takes Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

MQS Management LLC purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 7,659 shares of the company’s stock, valued at approximately $552,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. State Board of Administration of Florida Retirement System increased its position in shares of Prestige Consumer Healthcare by 77.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after purchasing an additional 11,000 shares in the last quarter. Lombard Odier Asset Management USA Corp purchased a new position in Prestige Consumer Healthcare during the 2nd quarter worth approximately $550,000. CANADA LIFE ASSURANCE Co increased its position in Prestige Consumer Healthcare by 19.4% during the first quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock worth $3,453,000 after buying an additional 7,715 shares during the period. Sequoia Financial Advisors LLC increased its position in Prestige Consumer Healthcare by 12.9% during the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock worth $708,000 after buying an additional 1,120 shares during the period. Finally, Atria Investments Inc purchased a new stake in Prestige Consumer Healthcare in the first quarter valued at approximately $1,246,000. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock opened at $82.32 on Thursday. The business has a 50 day simple moving average of $72.84 and a 200-day simple moving average of $70.00. Prestige Consumer Healthcare Inc. has a 12 month low of $56.61 and a 12 month high of $83.13. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10. The stock has a market capitalization of $4.07 billion, a PE ratio of 20.03, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, hitting the consensus estimate of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The company had revenue of $283.79 million during the quarter, compared to analysts’ expectations of $282.09 million. During the same quarter last year, the business earned $1.07 EPS. The business’s revenue was down .9% on a year-over-year basis. Equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on PBH shares. Jefferies Financial Group restated a “hold” rating and set a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson reissued a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a research report on Monday. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.20.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.